Physician profile
Mark A Rivkin
NPI 1427373265
$9,510.73
in general payments reported to CMS, 2019-2025
4 companies · $955 in 2025
The $955 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,014 · 2020: $1,250 · 2021: $631 · 2022: $978 · 2023: $587 · 2024: $1,096 · 2025: $955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2,597 · Food and Beverage: $40.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,597.47 |
| Food and Beverage | $40.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corelink, LLC | $6,959.64 | 2019-2023 | |
| Zavation Medical Products, LLC | $2,521.30 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $16.22 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Zimmer Biomet Holdings, INC. | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rivkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.